BioLight Life Sciences Ltd (BOLT) — Cash Flow Quality Index

Latest as of June 2024: -5.40x

BioLight Life Sciences Ltd (BOLT) has a Cash Flow Quality Index of -5.40x as of June 2024. Operating cash flow of ILA-4.53 Million is below net income of ILA838.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does BioLight Life Sciences Ltd generate cash to assess how effectively this company generates cash.

Cash Flow Quality Index

-5.40x
Operating CF / Net Income

Operating Cash Flow

ILA-4.53 Million
ILA

Net Income

ILA838.00K
ILA

Data as of

Jun 2024
Most recent filing

BioLight Life Sciences Ltd Cash Flow Quality Index (2018–2021)

Historical Cash Flow Quality Index for BioLight Life Sciences Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore long-term investment intensity of BioLight Life Sciences Ltd to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Quality Index for BioLight Life Sciences Ltd (2018–2021)

Year-by-year earnings quality comparison for BioLight Life Sciences Ltd. For live market cap and the full company financial profile, see BOLT market cap overview.

Year Quality Index Operating CF (ILA) Net Income YoY Change
2021 -26.25x ILA-10.03 Million ILA382.00K ▼ -5947.0%
2018 -0.43x ILA-22.39 Million ILA51.59 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.